Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)

Completed

Conditions studied: Dyskinesias, Movement Disorders, Parkinson Disease

In brief

The ultimate goal of this proposal is to reduce dyskinesia in Parkinson's Disease (PD) patients. Dyskinesias are abnormal movements, often caused by the standard treatment for PD symptoms, levodopa. In this study, we will test if biochemical devices are equal to the clinical rating system in measuring dyskinesias.

Key facts

Study ID

NCT00467597

Run by

US Department of Veterans Affairs

People needed

36

Starts

2006-04-01

Expected to finish

2013-10-01

Last updated by the study team

2014-11-26

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Clinical diagnosis of probable idiopathic Parkinson's Disease or no neurologic disease (no disease for controls only)
• At least 21 years of age
• Mini Mental Status Exam Score>=25

You may not qualify if…

• Evidence of psychosis (hallucinations or delusions) by history
• Any unstable medical condition
• Currently using dopamine blocking medication
• Currently taking anticoagulants or MAO inhibitors

Where it is running

• VA Medical Center, Portland — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.